There is a long-standing interest in exploring the relationship between blood-based
biomarkers and psychiatric disorders, despite their causal role being difficult to resolve in …

Brain morphology differs markedly between individuals with schizophrenia, but the cellular
and genetic basis of this heterogeneity is poorly understood. Here, we sought to determine …

Circular RNAs (circRNAs) are a covalently closed subclass of non-coding RNA molecules
formed by back splicing of linear precursor RNA. These molecules are relatively stable and …

Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …

While RNA expression appears to be altered in several brain disorders, the constraints of
postmortem analysis make it impractical for well-powered population studies and biomarker …

Measures of lung function are heritable, and thus, we sought to utilise genetics to propose
drug-repurposing candidates that could improve respiratory outcomes. Lung function …

Pneumonia remains one of the leading causes of death worldwide. In this study, we use
genome-wide meta-analysis of lifetime pneumonia diagnosis (N = 391,044) to identify four …

Data from observational studies have suggested an involvement of abnormal glycaemic
regulation in the pathophysiology of psychiatric illness. This may be an attractive target for …

Background Unpacking molecular perturbations associated with features of schizophrenia
is a critical step toward understanding phenotypic heterogeneity in this disorder. Recent …

The aetiology of schizophrenia is complex, heterogeneous, and involves interplay of many
genetic and environmental influences. While significant progress has been made in the …